158 related articles for article (PubMed ID: 28716060)
1. Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer.
Desmée S; Mentré F; Veyrat-Follet C; Sébastien B; Guedj J
BMC Med Res Methodol; 2017 Jul; 17(1):105. PubMed ID: 28716060
[TBL] [Abstract][Full Text] [Related]
2. Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.
Riglet F; Mentre F; Veyrat-Follet C; Bertrand J
AAPS J; 2020 Feb; 22(2):50. PubMed ID: 32076894
[TBL] [Abstract][Full Text] [Related]
3. Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches.
Desmée S; Mentré F; Veyrat-Follet C; Guedj J
AAPS J; 2015 May; 17(3):691-9. PubMed ID: 25739818
[TBL] [Abstract][Full Text] [Related]
4. Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy.
Kerioui M; Mercier F; Bertrand J; Tardivon C; Bruno R; Guedj J; Desmée S
Stat Med; 2020 Dec; 39(30):4853-4868. PubMed ID: 33032368
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial.
Finelli A; Beer TM; Chowdhury S; Evans CP; Fizazi K; Higano CS; Kim J; Martin L; Saad F; Saarela O
JAMA Netw Open; 2021 Jun; 4(6):e2112426. PubMed ID: 34129025
[TBL] [Abstract][Full Text] [Related]
6. A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 Trial.
Parr H; Porta N; Tree AC; Dearnaley D; Hall E
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1055-1068. PubMed ID: 36822374
[TBL] [Abstract][Full Text] [Related]
7. Real-time individual predictions of prostate cancer recurrence using joint models.
Taylor JM; Park Y; Ankerst DP; Proust-Lima C; Williams S; Kestin L; Bae K; Pickles T; Sandler H
Biometrics; 2013 Mar; 69(1):206-13. PubMed ID: 23379600
[TBL] [Abstract][Full Text] [Related]
8. Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.
Pauler DK; Finkelstein DM
Stat Med; 2002 Dec; 21(24):3897-911. PubMed ID: 12483774
[TBL] [Abstract][Full Text] [Related]
9. Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.
Desmée S; Mentré F; Veyrat-Follet C; Sébastien B; Guedj J
Biometrics; 2017 Mar; 73(1):305-312. PubMed ID: 27148956
[TBL] [Abstract][Full Text] [Related]
10. Bayesian multi-response nonlinear mixed-effect model: application of two recent HIV infection biomarkers.
Castel C; Sommen C; Chatignoux E; Le Strat Y; Alioum A
Int J Biostat; 2022 Nov; 18(2):455-471. PubMed ID: 34391216
[TBL] [Abstract][Full Text] [Related]
11. Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancer.
Götz TI; Lang EW; Prante O; Cordes M; Kuwert T; Ritt P; Ludwig B; Schmidkonz C
Nuklearmedizin; 2020 Sep; 59(5):365-374. PubMed ID: 32663888
[TBL] [Abstract][Full Text] [Related]
12. Using Hamiltonian Monte Carlo to estimate the log-linear cognitive diagnosis model via Stan.
Jiang Z; Carter R
Behav Res Methods; 2019 Apr; 51(2):651-662. PubMed ID: 29949073
[TBL] [Abstract][Full Text] [Related]
13. Online Bayesian modeling and prediction of nonlinear systems--Sequential Monte Carlo approach.
Matsumoto T
Methods Inf Med; 2007; 46(2):96-101. PubMed ID: 17347736
[TBL] [Abstract][Full Text] [Related]
14. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
[TBL] [Abstract][Full Text] [Related]
15. Bayesian joint modelling of longitudinal and time to event data: a methodological review.
Alsefri M; Sudell M; García-Fiñana M; Kolamunnage-Dona R
BMC Med Res Methodol; 2020 Apr; 20(1):94. PubMed ID: 32336264
[TBL] [Abstract][Full Text] [Related]
16. Joint models for dynamic prediction in localised prostate cancer: a literature review.
Parr H; Hall E; Porta N
BMC Med Res Methodol; 2022 Sep; 22(1):245. PubMed ID: 36123621
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers.
Zhao L; Feng D; Neelon B; Buyse M
Stat Med; 2015 May; 34(10):1733-46. PubMed ID: 25630845
[TBL] [Abstract][Full Text] [Related]
18. Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm.
Guhl M; Bertrand J; Fayette L; Mercier F; Comets E
AAPS J; 2024 Apr; 26(3):53. PubMed ID: 38722435
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen flare induced by
Castello A; Macapinlac HA; Lopci E; Santos EB
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2256-2263. PubMed ID: 29785515
[TBL] [Abstract][Full Text] [Related]
20. Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH.
Moreira DM; Howard LE; Sourbeer KN; Amarasekara HS; Chow LC; Cockrell DC; Pratson CL; Hanyok BT; Aronson WJ; Kane CJ; Terris MK; Amling CL; Cooperberg MR; Freedland SJ
Clin Genitourin Cancer; 2017 Feb; 15(1):60-66.e2. PubMed ID: 27692812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
